Jun Luo

Jun Luo

Auto-generated profile, based on publicly available information

Jun Luo

School of Pharmacy, Second Military Medical University of PLA, Shanghai 200433, China

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 March 2021 in Journal of Molecular Structure
Verified
Journal Article
Closed access
JLJun Luo
Jun Luo
BLBao-Shu Liu
Bao-Shu Liu
XZXin-Rong Zhang
Xin-Rong Zhang
RLRui-Ting Liu
Rui-Ting Liu

1 November 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
JLJun Luo
Jun Luo
BLBao-Shu Liu
Bao-Shu Liu
YZYun-Chang Zhang
Yun-Chang Zhang
BWBing-Kai Wang
Bing-Kai Wang
BGBei-Bei Guo
Bei-Bei Guo
TCTian-Heng Chen
Tian-Heng Chen

22 November 2006 in Acta Crystallographica Section C Crystal Structure Communications
Verified
Journal Article
Closed access
PDF file
JLJun Luo
Jun Luo
XZXin-Rong Zhang
Xin-Rong Zhang
LCLi-Li Cui
Li-Li Cui
WDWei-Quan Dai
Wei-Quan Dai
BLBao-Shu Liu
Bao-Shu Liu

15 May 2008 in Chinese Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
JLJun Luo
Jun Luo
XZXin‐Rong Zhang
Xin‐Rong Zhang
EGEn‐Qing Gao
En‐Qing Gao
WDWei‐Quan Dai
Wei‐Quan Dai
LCLi‐Li Cui
Li‐Li Cui
BLBao‐Shu Liu
Bao‐Shu Liu

14 February 2026 in Drug Delivery
Verified
Journal Article
Open access
GSGuangze Sang
Guangze Sang
SWSizhen Wang
Sizhen Wang
QTQiwei Tai
Qiwei Tai
YZYunchang Zhang
Yunchang Zhang
XWXufang Wang
Xufang Wang
BGBeibei Guo
Beibei Guo
Inflammatory bowel disease (IBD), an immune-mediated chronic gastrointestinal disease, is difficult to treat because its specific pathogenic mechanisms are currently unclear, and its recurrence rate is high. Probiotic therapies have been used to treat IBD; however, challenges, including poor digestive stability and unstable treatment effects, remain. Catechins are natural flavonoids with anti-inflammatory and anti-oxidant properties. In this study, we link catechins to the amino side chain of ethylene glycol chitosan through phenylboronic acid as a nano coating for probiotics, and enhance their stability under acidic conditions with sodium alginate. The resulting double-layer nano coating system is triggered by reactive oxygen species (ROS) for probiotic-small molecule combination therapy. After oral administration, the nano coating helps probiotics stabilize and pass through the harsh digestive environment, respond to the high ROS environment at the site of inflammation, and release anti-inflammatory drugs. The coating breaks down and adheres to the cell surface while releasing probiotics to regulate the intestinal microbiota environment and achieve combined therapy. The method exerts a certain therapeutic effect in a dextran sulfate sodium (DSS)-induced mouse model of ulcerative colitis. This study combines traditional targeted drug therapy concepts with biological therapies to improve IBD treatment efficacy and reduce side effects.